Rights

S2 Form for Planned Healthcare Abroad: EU Guide

The S2 form can authorise planned treatment in another European country through the public system. Learn when it applies, how costs work, and what to arrange before travelling.

By the Federal Europa editorial team Reviewed 2026-09-01

On this page

What S2 covers
Two routes to planned cross-border healthcare
Authorisation and the evidence to prepare
Treatment, costs and follow-up
Refusals and the wider purpose
Sources and review

What S2 covers

Portable Document S2, formerly called form E112, is proof that the public health insurer responsible for your cover has authorised specified planned treatment in another participating European country. You normally arrange authorisation before travelling, then present or register the document as instructed in the country of treatment.

S2 is not a general card for choosing any clinic or treatment abroad. The authorisation concerns the treatment, destination, provider route, and period accepted by the institutions. Care is then provided under the legislation of the country of treatment as though you were insured there, while the competent insurer remains responsible for the authorised cost under European social-security coordination.

Start by separating planned from unplanned care. If treatment becomes medically necessary during a temporary stay that was not made to obtain care, the European Health Insurance Card may apply. If the purpose of the trip is a consultation, diagnostic procedure, operation, course of therapy, or other arranged care, EHIC does not cover that planned treatment. Ask about S2 or the separate cross-border healthcare reimbursement route before booking.

Two routes to planned cross-border healthcare

European law provides two routes that are easy to confuse. Under Regulations 883/2004 and 987/2009, planned treatment requires prior authorisation and the approval is documented with S2. Treatment is delivered through providers covered by the destination country's statutory system, on the same charging rules as people insured there. Institutions may settle much of the bill between themselves, although local patient charges or an advance payment can still arise.

Under Directive 2011/24/EU, a patient can often arrange care and claim reimbursement from the home system afterwards. Prior authorisation is not required for every treatment, but a country may require it for care such as overnight hospital treatment, highly specialised or cost-intensive procedures, or other categories on its published list. The patient commonly pays first, and reimbursement is normally limited to what the home system would have paid for the same or similar covered care. Private providers may be possible under this route, subject to the national rules.

The two routes can produce different provider choices, cash-flow needs, tariffs, and geographic scope. Do not choose from a blog comparison alone. Ask the National Contact Point in the country where you are insured to explain both routes for the exact treatment and provider, including whether S2 is available or more advantageous, whether prior authorisation is mandatory, what you may have to pay, and which country rules cover travel or an accompanying person.

Authorisation and the evidence to prepare

For the S2 route, authorisation must be granted when the treatment is among the benefits provided by the relevant public system and it cannot be given where you live within a time limit that is medically justifiable for your individual condition. The assessment must take account of your current health and the probable course of the illness. A long published waiting list is useful evidence, but the legal test is personal and medical, not simply whether another country can offer an earlier date.

An insurer can refuse if the treatment is not among the benefits to which you are entitled or if appropriate care can be provided at home within a medically justifiable time. It should give reasons and identify review or appeal routes. It cannot treat the existence of a waiting list as the whole answer, and cost abroad alone is not a sufficient reason to refuse qualifying authorisation under the coordination route.

Build an evidence file before applying. Ask your treating clinician for the diagnosis, proposed treatment, clinical urgency, likely effect of delay, and relevant records. Obtain information from the destination provider about the exact procedure, proposed date, statutory-system status, estimated patient charges, and whether it accepts S2. Your insurer may have its own referral, specialist opinion, translation, or application requirements.

Apply to the public health insurance institution responsible for your cover. That may not be the country where you live: for example, an S1 holder can live in one country while another remains competent. Regulation 987/2009 provides a forwarding procedure when a person applies through the institution of the place of residence. In practice, ask both institutions which one will decide and keep proof of the date and documents submitted.

Do not make non-refundable travel plans until you have the written decision and the destination side has confirmed how to use it. Check the authorised treatment, provider or system, country, validity dates, number of sessions, and whether follow-up, devices, medicines, rehabilitation, or complications are included. A change in hospital, treatment plan, or date may require an amended authorisation.

Treatment, costs and follow-up

Before treatment, send or present S2 to the health insurance institution in the destination country as instructed, and confirm the practical route with the provider. Some systems arrange payment institution to institution. Others require the patient to pay the same statutory contribution as a locally insured person, or to pay first and seek reimbursement. Request a written estimate and keep the authorisation, invoices, medical reports, prescriptions, proof of payment, and correspondence.

S2 does not automatically make every cost disappear. Travel, ordinary accommodation, repatriation, translation, private upgrades, and an accompanying person's expenses are not automatically covered by EU law. When the competent country's own rules reimburse travel and stay inseparable from authorised treatment, comparable support must also be available for treatment in another member country. Ask for a written decision before assuming it applies.

After the treatment, obtain a discharge summary and a copy of your medical record. Confirm who will provide follow-up care, manage complications, renew medicines, and receive the clinical information at home. Your home system must not deny the follow-up that would have been available had the treatment occurred there, but clinical handover still needs to be organised in practice.

Refusals and the wider purpose

If authorisation is refused or delayed, request the decision, medical reasoning, evidence relied upon, deadline, and appeal route in writing. Supply updated clinical evidence if delay is worsening your condition. National Contact Points explain procedures; Your Europe Advice can clarify EU rights; SOLVIT may help when a public authority appears to misapply them. Urgent clinical decisions should remain with qualified professionals, not an administrative appeal alone.

S2 makes a shared European healthcare space practical without pretending Europe has one uniform health service. The right depends on coordinated national systems, clear authorisation, and safe clinical handover. A more federal Europe should make this route easier to compare and use, while keeping medical necessity, public accountability, and patient safety at its centre.

Which planned-care route are you using?

Public-system route

S2 prior authorisation

Apply before travel. Use a provider within the destination's statutory system and expect its local patient rules, with institutional settlement where available.

Reimbursement route

Cross-Border Healthcare Directive

Check whether prior approval is required, whether the provider qualifies, how much the home system would reimburse, and whether you must pay the full bill first.

Unexpected need

EHIC during a temporary stay

EHIC concerns medically necessary public care that cannot wait during a temporary stay; it does not authorise a trip made for planned treatment.

S2 application and treatment checklist

Ask the National Contact Point in the country where you are publicly insured to compare the S2 and Directive routes for the exact treatment.
Confirm that the treatment is covered by your public system and whether prior authorisation is required.
Get clinical evidence describing diagnosis, proposed treatment, urgency, expected effect of delay, and the medically justifiable timeframe.
Verify the destination provider's statutory-system status, S2 acceptance, proposed date, treatment plan, and estimated patient charges.
Apply to the competent public health insurer before booking non-refundable travel; keep proof of submission and every attachment.
Check the written authorisation for treatment, destination, provider route, dates, sessions, and any limits or exclusions.
Register or present S2 to the destination health insurance institution and provider exactly as instructed before care begins.
Confirm who pays first and whether travel, accommodation, an accompanying person, medicines, devices, rehabilitation, or follow-up are covered.
Carry the authorisation and records; keep itemised invoices, payment evidence, prescriptions, reports, and all correspondence.
Arrange clinical handover and follow-up at home, and use the written review or appeal route if authorisation is refused or delayed.

Check before you rely on it

Federal Europa keeps this friendly, but official details can depend on your country, route, status, timing, airline, seller, or document situation.

S2 is the prior-authorisation route under European social-security coordination; the Cross-Border Healthcare Directive is a separate route with different payment, provider, and authorisation rules.
The relevant public insurer and National Contact Point must confirm whether the treatment is covered, which route applies, and whether approval is required before travel.
S2 generally uses providers within the destination's statutory system and applies its patient-payment rules; it is not blanket approval for any private clinic.
A medically justifiable waiting time depends on the patient's condition and probable course of illness, not only a general waiting-list length.
Geographic and personal scope can differ between the coordination regulations, the Directive, EEA and Swiss arrangements, and post-Brexit rules; confirm the countries and your status.
This guide is orientation, not medical or legal advice. Obtain a clinical recommendation and written insurer decision for the individual treatment plan.

Plain-language FAQ

Questions people usually ask next

What is an S2 form?

Portable Document S2, formerly E112, is written prior authorisation from the public health insurer responsible for your cover to receive specified planned treatment in another participating European country through its statutory healthcare system.

Does an S2 form pay for all treatment abroad?

No. It covers the authorised treatment under the destination public system's rules. Local patient charges, travel, accommodation, private upgrades, translation, repatriation, and care outside the authorisation may remain payable.

Can an insurer refuse an S2 because there is treatment at home?

It may refuse if appropriate covered treatment can be provided at home within a medically justifiable time for your condition. It must assess your health and likely course of illness, explain the decision, and provide review or appeal routes.

What is the difference between S2 and EHIC?

S2 authorises a trip for specified planned treatment. EHIC is for medically necessary public healthcare that becomes needed during a temporary stay not made for the purpose of obtaining treatment.

Sources and review

Federal Europa keeps the friendly voice, but practical facts still need official or reliable sources.